Beam Therapeutics Inc. (BEAM)
NASDAQ: BEAM
· Real-Time Price · USD
17.85
-0.39 (-2.14%)
At close: May 13, 2025, 11:08 AM
Beam Therapeutics Revenue
Beam Therapeutics reported an annual revenue of $63.52M, reflecting a -83.18% growth. For the quarter ending March 31, 2025, Beam Therapeutics generated $7.47M in revenue.
Revenue (ttm)
$63.52M
Revenue Growth
-83.18%
Price / Sales Ratio
32.14
Revenue / Employee
$161.62K
Employees
393
Market Cap
1.79B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | % Change |
---|